NEUROGENE INC
NGNE·64135M105·US·Common Stock·Healthcare - Biotechnology-13D/G
NGNE (NEUROGENE INC) is held by 66 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($27.5M), BlackRock, Inc. ($20.3M), BAKER BROS. ADVISORS LP ($20M). Net institutional sentiment: Bullish.
66
Holders
Avg rating(15 Elite)
$182.4M
Total Value
68% (73)
Fund Consensus
42 buying - 20 selling
Who's Trading
InsiderCMCvijic Christine MikailSell $144KMay 6, 2026
InsiderCMCvijic Christine MikailSell $156KMay 6, 2026
InsiderMRMcMinn RachelSell $74KMar 26, 2026
InsiderCMCvijic Christine MikailSell $55KMar 26, 2026
InsiderJJJordan JulieSell $18KMar 26, 2026
InsiderCMCvijic Christine MikailSell $49KMar 13, 2026
InsiderCMCvijic Christine MikailSell $30KMar 13, 2026
InsiderCMCvijic Christine MikailSell $6KMar 13, 2026
ActivistRERedmile Group, LLC9.9%Feb 17, 2026
ActivistTETrails Edge Capital Partners, LP5.1%Dec 15, 2025
13F: Insider & Congress:
Showing 1-20 of 73
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer